Prabhudas Lilladhar
Online pharmacy startup PharmEasy announced acquisition of THYROCARE Technologies, with a view to add diagnostic services in its digital offerings through biochemistry/pathology business. PharmEasy's parent company API...
Thyrocare Technologies Ltd. is trading at high volume of 1.7M with price gain of 6.57.
More from Thyrocare Technologies Ltd.
Recommended